Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa)
therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately …

Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, IL-23A (p19)
and IL-12/23B (p40), the latter shared with Interleukin-12 (IL-12). IL-23 is mainly produced …

… Beginning with BPA’s disposition, this review summarizes recent findings on the neurotoxicity
of BPA and its analogues, on neuronal differentiation, synaptic plasticity, neuro…

… Importantly, to rule out the possibility that the result obtained was not due to associative
learning, we US) by 5 s and overlaps it for 25 s. Over extensive training (5 days, 100 trials per day…

… An unpaired Student’s t test was performed for statistical … An unpaired Student’s t test was
performed for statistical … Statistical analyses were made by one-way ANOVA using Scheffe’s …

… HSPC-derived microglia and the enzyme’s transfer to other neural and nonneural cells in the
… After evidence of significant effect of the treatment, we applied Scheffe’s procedure for post-…

l-dopa–induced dyskinesia (LID) is a common debilitating complication of dopamine
replacement therapy in Parkinson's disease. Recent evidence suggests that LID may be linked …

… Recent data have revealed BPA’s ability to induce epigenetic changes by modulating gene
expression, but not gene sequences, with consequences on gamete quality in both the sexes…

… of Alzheimer’s disease patients [265, 266] and in accelerated aging mice model [267].
Interestingly, decreased DHA distribution in Alzheimer’s disease patient’s brains correlates with …

… CLASI score and anti- dsDNA antibody levels were analyzed by Wilcoxon’s rank sum test,
Wilcoxon’s test for paired data, and ANOVA on ranks (followed by Friedman’s test for repeated …